Part II.
Other Information
Item 1.
Legal Proceedings
See Note 9.
“Commitments and Contingencies” within Item 1.
“Financial Statements.” for information regarding any legal proceedings in which we may be involved.
Table of Contents
Item 1A.
Risk factors
We are affected by risks specific to us as well as factors that affect all businesses operating in a global market.
The significant factors known to us that could materially adversely affect our business, financial condition, or operating results are described in our Annual Report on Form 10-K for the year ended March 31, 2018, under the heading “Part I – Item 1A.
Risk Factors.” There have been no material changes to those risk factors.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
On November 7, 2005, our Board of Directors adopted a share repurchase plan which allows for the repurchase of up to 300,000 of our common shares, of which 162,486 have been purchased to date.
This plan will continue until the maximum is reached or the plan is terminated by further action of the Board of Directors.
We have made no repurchases of our common stock in the current or any of the last three fiscal years.
Table of Contents
Item 6.
Exhibits
Table of Contents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MESA LABORATORIES, INC.
